Article

Bbarrons.com on 2021-12-16 16:09

Biogen Announces New Trial for Alzheimer’s drug Aduhelm2 min read

Biogen’s Alzheimer’s drug Aduhelm drew fire after its FDA approval, but the company's confirmatory trial is on a quicker-than-expected timeframe.

Michel Vounatsos

Related news

Biogen Sees Heavy Patient Interest in New Alzheimer’s Drug4 min read wsj.com
BBiogen After the Alzheimer’s Drug Debacle: Time to Sell the Parts? 4 min read barrons.com
BBiogen and Eisai Strengthen Lead in Alzheimer’s Drug Race. The Stocks Are Rising. 2 min read barrons.com
MBiogen and Eisai make plans to take another Alzheimer's drug to the FDA3 min read marketwatch.com
Switzerland , Canton of Solothurn , Japan , San Francisco
BBiogen to Eliminate Alzheimer's Drug Infrastructure, Search for New CEO1 min read barrons.com
BBiogen Searches for New CEO in Wake of Struggles With Alzheimer's Drug 4 min read barrons.com
BBiogen Soars 46% on Alzheimer’s Drug Trial. Mizuho Says the Stock Is a Buy.2 min read barrons.com
Stock Island , Mizuho-machi
BBiogen Stock Is Soaring as Hope Returns for Alzheimer’s Drug barrons.com
Wall Street , Stock Island
Biogen CEO: ‘Major bottleneck’ still limits Alzheimer’s drug Seattle Times
Massachusetts , Cambridge
Biogen cuts Alzheimer’s drug price 50% months after approval Seattle Times
New York , Cambridge
FBiogen predicts preventive Alzheimer’s drug ft.com
South East Asia , China
FFDA approves Biogen Alzheimer’s drug ft.com
BBiogen Earnings Were Good, but an Alzheimer’s Drug Delay Hits Shares barrons.com
Stock Island , Massachusetts
BBiogen Is Spiking Because Its Alzheimer’s Drug Takes Another Step Toward Approval barrons.com
Stock Island
BBiogen’s Alzheimer’s Drug Has Another Shot at Success3 min read barrons.com
Wall Street
BBiogen Stock Climbed on Surprise Alzheimer’s Drug News. The Effects Could Be Lasting.barrons.com
Panels find FDA, Biogen rushed Alzheimer’s drug Arkansas Online
Philadelphia , Cambridge